Hercules Capital Net Profit Margin 2010-2023 | HTGC
Hercules Capital net profit margin from 2010 to 2023. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Hercules Capital Net Profit Margin Historical Data |
| Date |
TTM Revenue |
TTM Net Income |
Net Margin |
| 2023-12-31 |
$0.46B |
$0.34B |
73.32% |
| 2023-09-30 |
$0.44B |
$0.28B |
64.16% |
| 2023-06-30 |
$0.41B |
$0.31B |
75.56% |
| 2023-03-31 |
$0.36B |
$0.20B |
55.68% |
| 2022-12-31 |
$0.32B |
$0.10B |
32.09% |
| 2022-09-30 |
$0.29B |
$0.04B |
15.02% |
| 2022-06-30 |
$0.28B |
$0.02B |
5.38% |
| 2022-03-31 |
$0.28B |
$0.11B |
38.99% |
| 2021-12-31 |
$0.28B |
$0.18B |
62.28% |
| 2021-09-30 |
$0.28B |
$0.32B |
113.38% |
| 2021-06-30 |
$0.28B |
$0.34B |
120.07% |
| 2021-03-31 |
$0.28B |
$0.32B |
113.48% |
| 2020-12-31 |
$0.29B |
$0.23B |
79.09% |
| 2020-09-30 |
$0.28B |
$0.12B |
42.76% |
| 2020-06-30 |
$0.28B |
$0.10B |
34.40% |
| 2020-03-31 |
$0.28B |
$0.08B |
29.33% |
| 2019-12-31 |
$0.27B |
$0.17B |
64.55% |
| 2019-09-30 |
$0.25B |
$0.11B |
43.70% |
| 2019-06-30 |
$0.24B |
$0.13B |
53.36% |
| 2019-03-31 |
$0.22B |
$0.13B |
59.82% |
| 2018-12-31 |
$0.21B |
$0.08B |
36.36% |
| 2018-09-30 |
$0.20B |
$0.11B |
54.95% |
| 2018-06-30 |
$0.20B |
$0.11B |
55.90% |
| 2018-03-31 |
$0.19B |
$0.09B |
46.63% |
| 2017-12-31 |
$0.19B |
$0.08B |
41.05% |
| 2017-09-30 |
$0.19B |
$0.07B |
39.57% |
| 2017-06-30 |
$0.19B |
$0.07B |
38.17% |
| 2017-03-31 |
$0.18B |
$0.05B |
25.82% |
| 2016-12-31 |
$0.18B |
$0.07B |
38.29% |
| 2016-09-30 |
$0.17B |
$0.07B |
40.12% |
| 2016-06-30 |
$0.17B |
$0.04B |
24.26% |
| 2016-03-31 |
$0.16B |
$0.03B |
20.86% |
| 2015-12-31 |
$0.16B |
$0.04B |
26.28% |
| 2015-09-30 |
$0.15B |
$0.05B |
30.52% |
| 2015-06-30 |
$0.14B |
$0.06B |
40.28% |
| 2015-03-31 |
$0.14B |
$0.07B |
49.29% |
| 2014-12-31 |
$0.14B |
$0.07B |
48.61% |
| 2014-09-30 |
$0.14B |
$0.08B |
53.57% |
| 2014-06-30 |
$0.14B |
$0.10B |
67.36% |
| 2014-03-31 |
$0.15B |
$0.11B |
72.41% |
| 2013-12-31 |
$0.14B |
$0.10B |
70.71% |
| 2013-09-30 |
$0.13B |
$0.10B |
73.88% |
| 2013-06-30 |
$0.12B |
$0.07B |
56.41% |
| 2013-03-31 |
$0.11B |
$0.05B |
42.45% |
| 2012-12-31 |
$0.10B |
$0.05B |
47.42% |
| 2012-09-30 |
$0.09B |
$0.04B |
41.76% |
| 2012-06-30 |
$0.09B |
$0.04B |
46.51% |
| 2012-03-31 |
$0.08B |
$0.06B |
77.11% |
| 2011-12-31 |
$0.08B |
$0.05B |
57.50% |
| 2011-09-30 |
$0.08B |
$0.04B |
53.95% |
| 2011-06-30 |
$0.07B |
$0.03B |
36.99% |
| 2011-03-31 |
$0.07B |
$-0.00B |
-2.99% |
| 2010-12-31 |
$0.06B |
$0.01B |
8.20% |
| 2010-09-30 |
$0.06B |
$0.00B |
1.64% |
| 2010-06-30 |
$0.06B |
$0.02B |
34.92% |
| 2010-03-31 |
$0.07B |
$0.01B |
20.90% |
| 2009-12-31 |
$0.07B |
$0.01B |
16.22% |
| Sector |
Industry |
Market Cap |
Revenue |
| Finance |
Finance - SBIC & Commercial |
$3.131B |
$0.461B |
|
Hercules Capital is a specialty finance company that provides venture capital to technology and life science-related companies. The company also has offices in Boston, New York, Bethesda and San Diego. Its client list includes selected publicly listed companies, privately held companies backed by leading venture capital, private equity firms and lower middle-market companies. The company offers customized financing solutions ranging from senior debt to equity capital, with a focus on structured debt with warrants.
|
